Cargando…
Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis
Open innovation in medical and pharmaceutical research has grown steadily over the last decade. However, the performance of the published literature in terms of the scientific impact and gaining social media attention remains largely unexplored. The scientific literature of open innovation was exami...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840485/ https://www.ncbi.nlm.nih.gov/pubmed/33519448 http://dx.doi.org/10.3389/fphar.2020.587526 |
_version_ | 1783643583729893376 |
---|---|
author | Yeung, Andy Wai Kan Atanasov, Atanas G. Sheridan, Helen Klager, Elisabeth Eibensteiner, Fabian Völkl-Kernsock, Sabine Kletecka-Pulker, Maria Willschke, Harald Schaden, Eva |
author_facet | Yeung, Andy Wai Kan Atanasov, Atanas G. Sheridan, Helen Klager, Elisabeth Eibensteiner, Fabian Völkl-Kernsock, Sabine Kletecka-Pulker, Maria Willschke, Harald Schaden, Eva |
author_sort | Yeung, Andy Wai Kan |
collection | PubMed |
description | Open innovation in medical and pharmaceutical research has grown steadily over the last decade. However, the performance of the published literature in terms of the scientific impact and gaining social media attention remains largely unexplored. The scientific literature of open innovation was examined by means of bibliometric analyses to identify the most prolific authors, organizations, countries, journals, research areas, and recurring terms. By accessing the Web of Science Core Collection and Altmetric electronic databases, citation-related and Altmetric data were evaluated. Public-private partnerships and a selection of newly introduced potential novel drugs in the analyzed publications were identified. North America and Europe were the major literature contributors. Research outputs were mainly published in journals focused on business and economics, pharmacology and pharmacy, and engineering. Many pharmaceutical and biotechnological companies contributed to the analyzed publications, with higher mean citation counts and social media attention (Altmetric score) than nonindustry articles. Public-private partnerships fostered financial support, sharing of expertise and intellectual property, and research collaborations. In summary, open innovation might serve as a powerful strategy to both benefit the involved industry entities and accelerate the development of solutions and products for the betterment of human health. |
format | Online Article Text |
id | pubmed-7840485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78404852021-01-29 Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis Yeung, Andy Wai Kan Atanasov, Atanas G. Sheridan, Helen Klager, Elisabeth Eibensteiner, Fabian Völkl-Kernsock, Sabine Kletecka-Pulker, Maria Willschke, Harald Schaden, Eva Front Pharmacol Pharmacology Open innovation in medical and pharmaceutical research has grown steadily over the last decade. However, the performance of the published literature in terms of the scientific impact and gaining social media attention remains largely unexplored. The scientific literature of open innovation was examined by means of bibliometric analyses to identify the most prolific authors, organizations, countries, journals, research areas, and recurring terms. By accessing the Web of Science Core Collection and Altmetric electronic databases, citation-related and Altmetric data were evaluated. Public-private partnerships and a selection of newly introduced potential novel drugs in the analyzed publications were identified. North America and Europe were the major literature contributors. Research outputs were mainly published in journals focused on business and economics, pharmacology and pharmacy, and engineering. Many pharmaceutical and biotechnological companies contributed to the analyzed publications, with higher mean citation counts and social media attention (Altmetric score) than nonindustry articles. Public-private partnerships fostered financial support, sharing of expertise and intellectual property, and research collaborations. In summary, open innovation might serve as a powerful strategy to both benefit the involved industry entities and accelerate the development of solutions and products for the betterment of human health. Frontiers Media S.A. 2021-01-14 /pmc/articles/PMC7840485/ /pubmed/33519448 http://dx.doi.org/10.3389/fphar.2020.587526 Text en Copyright © 2021 Yeung, Atanasov, Sheridan, Klager, Eibensteiner, Völkl-Kernsock, Kletecka-Pulker, Willschke and Schaden. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yeung, Andy Wai Kan Atanasov, Atanas G. Sheridan, Helen Klager, Elisabeth Eibensteiner, Fabian Völkl-Kernsock, Sabine Kletecka-Pulker, Maria Willschke, Harald Schaden, Eva Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis |
title | Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis |
title_full | Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis |
title_fullStr | Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis |
title_full_unstemmed | Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis |
title_short | Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis |
title_sort | open innovation in medical and pharmaceutical research: a literature landscape analysis |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840485/ https://www.ncbi.nlm.nih.gov/pubmed/33519448 http://dx.doi.org/10.3389/fphar.2020.587526 |
work_keys_str_mv | AT yeungandywaikan openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis AT atanasovatanasg openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis AT sheridanhelen openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis AT klagerelisabeth openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis AT eibensteinerfabian openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis AT volklkernsocksabine openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis AT kleteckapulkermaria openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis AT willschkeharald openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis AT schadeneva openinnovationinmedicalandpharmaceuticalresearchaliteraturelandscapeanalysis |